Efficacy and Safety of Calcipotriene 0.005% Foam for the Treatment of Plaque-Type Psoriasis: Results of Two Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Phase III Clinical Trials

By Feldman Steven R.  

American Journal of Clinical Dermatology, Vol. 13, Iss. 4, 2012-08 ,pp. : 261-271

Adis International

Access to resources Recommend Favorite

Use of Calcipotriene Cream (Dovonex® Cream) Following Acute Treatment of Psoriasis Vulgaris with the Calcipotriene/Betamethasone Dipropionate Two-Compound Product (Taclonex®): A Randomized, Parallel-Group Clinical Trial

By White Stephen  

American Journal of Clinical Dermatology, Vol. 7, Iss. 3, 2006-01 ,pp. : 177-184

Adis International

Access to resources Recommend Favorite

The Efficacy of Calcipotriol + Acitretin Combination Therapy for Psoriasis: Comparison with Acitretin Monotherapy

By Rim J.H.   Park J.Y.   Choe Y.B.   Youn J.I.  

American Journal of Clinical Dermatology, Vol. 4, Iss. 7, 2003-01 ,pp. : 507-510

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of the Betamethasone Valerate 0.1% Plaster in Mild-to-Moderate Chronic Plaque Psoriasis: A Randomized, Parallel-Group, Active-Controlled, Phase III Study

By Naldi Luigi  

American Journal of Clinical Dermatology, Vol. 12, Iss. 3, 2011-06 ,pp. : 191-201

Adis International

Access to resources Recommend Favorite

Briakinumab for the Treatment of Plaque Psoriasis

By Traczewski Pawel   Rudnicka Lidia  

BioDrugs, Vol. 26, Iss. 1, 2012-02 ,pp. : 9-20

Adis International

Access to resources Recommend Favorite